IRIS
DE STEFANO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.868
EU - Europa 24.593
AS - Asia 15.840
SA - Sud America 2.989
AF - Africa 790
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 27
Totale 82.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.417
GB - Regno Unito 6.383
CN - Cina 5.242
SG - Singapore 4.487
RU - Federazione Russa 4.401
IE - Irlanda 3.153
IT - Italia 2.841
BR - Brasile 2.466
UA - Ucraina 2.017
HK - Hong Kong 1.989
FR - Francia 1.517
VN - Vietnam 1.380
SE - Svezia 1.353
DE - Germania 1.228
KR - Corea 852
FI - Finlandia 730
BD - Bangladesh 477
IN - India 370
ZA - Sudafrica 340
NL - Olanda 218
CA - Canada 217
AR - Argentina 185
ES - Italia 183
NG - Nigeria 169
TR - Turchia 158
IQ - Iraq 154
MX - Messico 132
PK - Pakistan 98
AT - Austria 94
BE - Belgio 91
EC - Ecuador 87
JP - Giappone 83
PL - Polonia 77
ID - Indonesia 60
CO - Colombia 57
PH - Filippine 57
SA - Arabia Saudita 55
VE - Venezuela 55
AU - Australia 53
CL - Cile 53
MA - Marocco 50
KE - Kenya 49
UZ - Uzbekistan 44
CZ - Repubblica Ceca 36
DZ - Algeria 36
RO - Romania 35
CI - Costa d'Avorio 34
IR - Iran 34
PY - Paraguay 33
NP - Nepal 32
AE - Emirati Arabi Uniti 31
IL - Israele 31
EG - Egitto 29
TN - Tunisia 29
CH - Svizzera 27
JO - Giordania 27
MK - Macedonia 25
AZ - Azerbaigian 24
JM - Giamaica 24
EU - Europa 23
KZ - Kazakistan 22
MY - Malesia 20
PE - Perù 20
LT - Lituania 19
RS - Serbia 19
UY - Uruguay 19
GR - Grecia 17
BG - Bulgaria 16
MD - Moldavia 14
AL - Albania 13
DO - Repubblica Dominicana 13
SN - Senegal 13
HU - Ungheria 12
OM - Oman 12
SY - Repubblica araba siriana 12
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
PT - Portogallo 11
TH - Thailandia 11
BO - Bolivia 10
LB - Libano 10
HN - Honduras 9
KG - Kirghizistan 9
BY - Bielorussia 8
CG - Congo 8
CR - Costa Rica 8
DK - Danimarca 8
TT - Trinidad e Tobago 8
BH - Bahrain 7
ET - Etiopia 7
HR - Croazia 7
NO - Norvegia 7
PA - Panama 7
BB - Barbados 6
GE - Georgia 6
GT - Guatemala 6
LU - Lussemburgo 6
AM - Armenia 5
BN - Brunei Darussalam 5
LV - Lettonia 5
Totale 82.069
Salva come PNG Salva come JPEG
Città #
Southend 5.637
Dallas 4.646
Fairfield 4.003
Dublin 3.137
Houston 3.060
Ashburn 2.530
Singapore 2.384
Chandler 1.954
Woodbridge 1.917
Jacksonville 1.663
Wilmington 1.585
Seattle 1.580
Cambridge 1.390
Hong Kong 1.311
Menlo Park 1.283
Beijing 1.132
Santa Clara 1.118
Moscow 1.088
Hefei 1.057
San Jose 1.053
Seoul 842
Princeton 752
Ann Arbor 708
The Dalles 634
Nanjing 559
Siena 508
Los Angeles 451
Ho Chi Minh City 420
Council Bluffs 389
Lauterbourg 381
Milan 361
Hanoi 360
New York 311
Helsinki 299
Johannesburg 296
Boardman 284
San Mateo 258
Buffalo 243
São Paulo 222
San Diego 218
Nanchang 212
Columbus 176
Shenyang 162
Abuja 161
Florence 147
Munich 146
Rome 137
Málaga 117
Dong Ket 113
Norwalk 111
London 104
Orem 102
Tianjin 102
Bengaluru 97
Hebei 94
Changsha 92
Frankfurt am Main 86
Redondo Beach 83
Jiaxing 78
Lancaster 78
Düsseldorf 77
Kunming 77
Amsterdam 76
Chicago 76
Shanghai 74
San Francisco 72
Brussels 68
Dearborn 68
Rio de Janeiro 68
Toronto 66
Chennai 64
Brooklyn 63
Jinan 62
Falls Church 61
Tokyo 61
Warsaw 60
Belo Horizonte 59
Turku 59
Baghdad 57
Guangzhou 57
Vienna 57
Hangzhou 56
Lappeenranta 55
Brasília 54
Izmir 54
Montreal 54
Nuremberg 52
Haiphong 51
Phoenix 51
Stockholm 50
Zhengzhou 50
Curitiba 49
Da Nang 43
Mexico City 42
Boston 40
Denver 40
Atlanta 39
Ningbo 37
Tashkent 37
Pisa 36
Totale 56.694
Salva come PNG Salva come JPEG
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 783
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 589
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 484
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 476
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 472
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 449
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 396
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 369
A Rett syndrome MECP2 mutation that causes mental retardation in men 367
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 357
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 353
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 342
1H-MR Spectroscopy in Traumatic Brain Injury 336
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 334
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 328
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 328
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 317
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 309
A human post-mortem brain model for the standardization of multi-centre MRI studies 303
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 299
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 299
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 290
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 289
A case of ovarioleukodystrophy without elF2B mutations 285
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 285
Diffuse brain damage in normal tension glaucoma 282
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 281
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 279
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 278
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 277
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 275
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 274
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 274
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 270
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 270
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 261
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 260
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 258
Assessing response to interferon-β in a multicenter dataset of patients with MS 256
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 254
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 254
Automated identification of brain new lesions in multiple sclerosis using subtraction images 253
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 252
Chemical pathology of acute demyelinating lesions and its correlation with disability 251
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 250
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 249
Genetic leukoencephalopaties with unknown metabolic pathogenesis 248
Serial KL-6 measurements in COVID-19 patients 248
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 246
CADASIL and cerebrovascular diseases 245
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 245
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 244
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 244
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 244
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis 242
Brain atrophy assessment in multiple sclerosis: importance and limitations 242
Acute visual loss due to anterior ischemic optic neuropathy as first symptom in a patient with CADASIL 242
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 241
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 241
Altered Large-Scale Brain Functional Connectivity in Ocular Hypertension 241
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 240
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 240
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 240
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 240
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 239
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 239
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 239
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 239
A practical review of the neuropathology and neuroimaging of multiple sclerosis 237
Fingolimod effect on brain volume loss independently contributes to its effect on disability 235
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 234
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 233
Scoring treatment response in patients with relapsing multiple sclerosis 233
Early changes of brain connectivity in primary open angle glaucoma 233
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 232
A Novel Mutation in the Notch3 Gene in an Italian Family with CADASIL: Genetic and MRI Spectroscopic Findings 232
Cortical lesions in radiologically isolated syndrome. 231
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 231
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 230
A multicentre study of motor functional connectivity changes in patients with multiple sclerosis 230
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 229
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 228
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 227
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 227
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 227
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 226
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 225
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 225
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 225
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 223
Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience 222
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 221
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 220
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 220
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 219
Deep gray matter volume loss drives disability worsening in multiple sclerosis 218
Progression of regional grey matter atrophy in multiple sclerosis 218
Vitamin E deficiency secondary to chronic intestinal malabsorption and effect of vitamin supplement: a case report 216
Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency 215
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 213
Totale 27.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.444
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021490 0 0 0 0 0 0 0 0 0 0 0 490
2021/20225.254 333 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/202511.415 313 541 794 1.169 1.053 464 392 815 836 579 1.170 3.289
2025/202625.758 2.181 4.068 3.782 2.551 4.088 1.058 2.914 848 1.013 1.433 1.097 725
Totale 83.059